An analysis of patients with NSCLC and brain metastases at diagnosis found intracranial pressure and seizures had no impact, but other neurologic defects had an effect on overall survival.
Risk factors for melanoma metastasis differ depending on whether the route is through the lymphatic system or the blood. These findings were published in JAMA Dermatology.1 Cutaneous melanoma is widely thought to spread through both lymphatic and hematogenous routes. The former route is believed to involve locoregional disease spread to skin and lymph nodes whereas…
[OncoTargets and Therapy] This report presents case studies of two patients with breast cancer BM (BCBM) who reacted to two different forms of endocrine therapy.
Researchers used data from the National Cancer Database to evaluate the overall survival of patients who presented with cutaneous MBM from 2010 to 2015.
Combination therapy with lenvatinib and pembrolizumab is granted Breakthrough Therapy Designation for the treatment of advanced or metastatic renal cell carcinoma (RCC).
Two studies evaluate use of deep learning algorithm; one for breast cancer, the other for diabetic retinopathy
Median overall survival from time of diagnosis has increased from 7.5 to 22.7 months in the last decade.
A recent study found that nodal tumors and distant metastases originate from different areas of the primary tumor, suggesting that cancer spreads independently of the lymph nodes.
Patients with metastatic kidney cancer may also have an primary lung cancer that has gone gone undiagnosed.
Treatment expectations of individuals with metastatic prostate cancer and their health care providers often do not match.
